Status:

COMPLETED

Single Dose Azithromycin in the Treatment of Adult Cholera

Lead Sponsor:

International Centre for Diarrhoeal Disease Research, Bangladesh

Collaborating Sponsors:

Pfizer

Tufts Medical Center

Conditions:

Cholera

Eligibility:

All Genders

18-60 years

Phase:

PHASE3

Brief Summary

Cholera remains an important cause of diarrhoeal illness and death in Asia, Africa and Latin America. Antimicrobial therapy is an important adjunct to fluid therapy in the management of patients with ...

Detailed Description

A total of 182 evaluable patients (those with a positive stool culture for V. cholerae O1 or V. cholerae O139 and remain in the study for full 5 days) will be required for this study. Patients who me...

Eligibility Criteria

Inclusion

  • Age: 18 - 60 years
  • Gender: Male (To facilitate accurate measurement of stool and urine, and also due to the difficulties in hospitalizing women for longer duration)
  • Duration of illness: 24 hours or less
  • Written informed consent for participation in the study
  • Dehydration status: Signs of severe dehydration as determined by World Health Organization criteria.
  • Positive stool dark-field microscopic examination for V. cholerae, and subsequent isolation of V. cholerae O1 or O139 from an admission culture of a stool or rectal swab sample.

Exclusion

  • History of receiving even one dose of an antimicrobial agent effective in the treatment of cholera, and even a single fose of the drugs under evaluation.
  • Concomitant infection requiring antimicrobial therapy other than the study drugs which may interfere with evaluation of either the efficacy or safety of the study drugs.
  • A concomitant illness which may confound evaluation of outcome or is a contraindication for use of either of the study drugs (chronic heart, lung, of kidney disease, or instance), or conditions which may confound evaluation of adverse events of the study drugs.

Key Trial Info

Start Date :

December 1 2002

Trial Type :

INTERVENTIONAL

End Date :

May 1 2004

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT00229944

Start Date

December 1 2002

End Date

May 1 2004

Last Update

July 21 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dhaka Hospital, International Centre for Diarrhoeal Disease Research, Bangladesh

Dhaka, Bangladesh, 1212